This article provides a perspective and review on the development of Factor Xa inhibitors as next-generation antithrombotic agents.
This article provides a perspective on the development of Factor Xa inhibitors as next-generation antithrombotic agents.
ADVERTISEMENT RETURN TO ISSUEPerspectiveNEXTFactor Xa Inhibitors: Next-Generation Antithrombotic AgentsDonald J. P. Pinto, Joanne M. Smallheer, Daniel L. Cheney, Robert M. Knabb, and Ruth R. Wexler*View Author Information Research and Development, Bristol-Myers Squibb Company, P.O. Box 5400, Princeton, New Jersey, 08543*To whom correspondence should be addressed. Phone: (609) 818-5450. Fax: (609) 818-3331. E-mail: email protectedCite this: J. Med. Chem. 2010, 53, 17, 6243–6274Publication Date (Web):May 26, 2010Publication History Received3 February 2010Published online26 May 2010Published inissue 9 September 2010https://pubs.acs.org/doi/10.1021/jm100146hhttps://doi.org/10.1021/jm100146hreview-articleACS PublicationsCopyright © 2010 American Chemical SocietyRequest reuse permissionsArticle Views6420Altmetric-Citations115LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose SUBJECTS:Bioavailability,Inhibitors,Monomers,Peptides and proteins,Rodent models Get e-Alerts
Pinto et al. (Wed,) reported a review. Factor Xa Inhibitors was evaluated. This article provides a perspective and review on the development of Factor Xa inhibitors as next-generation antithrombotic agents.